Immutep Limited IMMP NASDAQ

Immutep Limited (IMMP) reported total assets of $156.98M and total liabilities of $13.35M for fiscal year 2025, resulting in total equity of $143.64M.

The company held $129.69M in cash and short-term investments. Total debt stood at $1.63M, with net debt of $-65.78M. The Debt-to-Equity (D/E) ratio was 0.01 (conservative).

Current ratio is 11.69, indicating strong short-term liquidity.

Criteria supported by this page:

• HEALTH (100/100, Pass) — Debt-to-Equity of 0.01, current ratio of 11.69 — balance sheet is strong
• MOAT (0/100) — Total assets $156.98M and equity $143.64M support the company's competitive scale
• VALUE (100/100) — Debt-to-Equity 0.01 contributes to the overall valuation risk assessment

Overall SharesGrow Score: 47/100 with 3/7 criteria passed.

VECT

VectivBio Holding AG

$16.87

+0.12%

ZURA

Zura Bio Limited

$5.69

-0.52%

ELEV

Elevation Oncology, Inc.

$0.37

-2.12%

AVRO

AVROBIO, Inc.

$1.40

-1.41%

CNSP

CNS Pharmaceuticals, Inc.

$2.75

+4.17%

ZVSA

ZyVersa Therapeutics, Inc.

$0.19

+0.00%

ENVB

Enveric Biosciences, Inc.

$2.03

+4.10%

CWBR

CohBar, Inc.

$0.41

+0.00%